Search Results - "Santhanagopolan, Sujatha M"

TCRs used in cancer gene therapy cross-react with MART-1/Melan-A tumor antigens via distinct mechanisms by Borbulevych, Oleg Y, Santhanagopolan, Sujatha M, Hossain, Moushumi, Baker, Brian M

“…T cells engineered to express TCRs specific for tumor Ags can drive cancer regression. The first TCRs used in cancer gene therapy, DMF4 and DMF5, recognize two…”
Get full text

Loss of T cell antigen recognition arising from changes in peptide and major histocompatibility complex protein flexibility: implications for vaccine design by Insaidoo, Francis K, Borbulevych, Oleg Y, Hossain, Moushumi, Santhanagopolan, Sujatha M, Baxter, Tiffany K, Baker, Brian M

“…Modification of the primary anchor positions of antigenic peptides to improve binding to major histocompatibility complex (MHC) proteins is a commonly used…”
Get full text

Loss of T Cell Antigen Recognition Arising from Changes in Peptide and Major Histocompatibility Complex Protein Flexibility: Implications for Vaccine Design by Insaidoo, Francis K., Borbulevych, Oleg Y., Hossain, Moushumi, Santhanagopolan, Sujatha M., Baxter, Tifany K., Baker, Brian M.

Get full text

T cell receptors used in cancer gene therapy cross-react with MART-1/Melan-A tumor antigens via distinct mechanisms1 by Borbulevych, Oleg Y., Santhanagopolan, Sujatha M., Hossain, Moushumi, Baker, Brian M.

“…T cells engineered to express T cell receptors (TCRs) specific for tumor antigens can drive cancer regression. The first TCRs used in cancer gene therapy, DMF4…”
Get full text

Loss of T Cell Antigen Recognition Arising from Changes in Peptide and Major Histocompatibility Complex Protein Flexibility by Insaidoo, Francis K., Borbulevych, Oleg Y., Hossain, Moushumi, Santhanagopolan, Sujatha M., Baxter, Tiffany K., Baker, Brian M.

“…Modification of the primary anchor positions of antigenic peptides to improve binding to major histocompatibility complex (MHC) proteins is a commonly used…”
Get full text